(Health-NewsWire.Net, August 23, 2017 ) GlobalData's Medical Devices sector report, "Inhalers-Medical Devices Pipeline Assessment, 2017" provides an overview of Inhalers currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inhalers pipeline products.
For more information about this report at http://www.reportsweb.com/inhalers-medical-devices-pipeline-assessment-2017
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
Scope
-Extensive coverage of the Inhalers under development -The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities -The report reviews the major players involved in the development of Inhalers and list all their pipeline projects -The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage -The report provides key clinical trial data of ongoing trials specific to pipeline products -Recent developments in the segment / industry
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001985403/sample
Reasons to buy
The report enables you to- -Formulate significant competitor information, analysis, and insights to improve R&D strategies -Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage -Identify and understand important and diverse types of Inhalers under development -Develop market-entry and market expansion strategies -Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline -In-depth analysis of the product's current stage of development, territory and estimated launch date
Companies Mentioned Acorda Therapeutics Inc Adamis Pharmaceuticals Corp Advent Pharmaceuticals Pty Ltd Aespira Ltd. AKELA Pharma Inc. Alexza Pharmaceuticals Inc Aradigm Corp Bayer HealthCare AG Bellerophon Therapeutics Inc Bespak Europe Ltd Boehringer Ingelheim GmbH Circassia Pharmaceuticals Plc Drexel University FocusStart LLC GlaxoSmithKline Plc MannKind Corp Medihale Ltd Monash University Nanotherapeutics Inc Nektar Therapeutics Nicoventures Trading Ltd North Carolina State University Novartis AG OPKO Health Inc Pharmaxis Ltd Inquire for Report at http://www.reportsweb.com/inquiry&RW0001985403/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|